🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMetabolic Health & DiabetesHOMA-IR tracking on GLP-1 — need advice Page 3

HOMA-IR tracking on GLP-1 — need advice

NurseLeah_Nash Sat, Mar 28, 2026 at 6:07 AM 14 replies 762 viewsPage 3 of 3
pete_RVA
Member
178
890
Dec 2024
Richmond, VA
Mar 30, 2026 at 2:00 PM#11
Dr.RheumBOS said:
HbA1c reflects roughly three months of average glycaemia weighted toward the most recent weeks, which is why repeating it at six weeks tells you very…

Genuinely useful, thank you. I had the facts and not the framework. Printing the relevant bit and taking it with me.

Last edited: Mar 30, 2026 at 7:00 PM
12 10mike_mod, SarahChen_PharmD, sarah.morrison and 9 others
Reply Quote Save Share Report
pat_auckland
Member
345
1,567
Jun 2024
Auckland, NZ
Mar 31, 2026 at 3:01 AM#12

Adding the clinical framing, because it changes how the question reads. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

13 11wanda_boise, NurseAsh_DET, BenResearch_OR and 10 others
Reply Quote Save Share Report
JessicaH_TX
Senior Member
4,123
13,456
Dec 2023
Houston, TX
Mar 31, 2026 at 4:01 PM#13
jim_asheville said:
My experience ordering cross-border ordering internationally: I've ordered from an Australian compounder.

Pushing back on jim_asheville here. I think the framing smuggles in the conclusion. Ask it the other way round and the obvious answer reverses, which usually means the question is doing the work.

Worth separating that from glycaemic control, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

Last edited: Mar 31, 2026 at 8:01 PM
14 12kim_atl_prep, sarah_TO, wendy_avl and 11 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
Dr.RaviCardio
VIP Member
2,890
15,678
Jan 2024
New York, NY
Apr 1, 2026 at 5:01 AM#14

One concrete data point for the thread. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

15 13hans_munich, jason_sac26, chris_chi24 and 12 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Apr 1, 2026 at 6:01 PM#15

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part. No action needed from anybody.

16 14PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 13 others
Reply Quote Save Share Report

Similar Threads

SUSTAIN-6 to SELECT — the cardiovascular evidence timeline14 replies
GLP-1 and insulin resistance — HOMA-IR improvement data17 replies
Metabolic syndrome reversal criteria — how GLP-1 addresses all 55 replies
A1C target achievement rates — sema vs tirz comparison8 replies
SURPASS-CVOT: tirzepatide cardiovascular outcomes trial design3 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register